Big Tuna and automated buffer exchange: An interview with Unchained Labs

In this interview, AZoNetwork speaks with Joe Barco, the Senior Director of Workflow Marketing at Unchained Labs, about the benefits of automated buffer exchange with Big Tuna.

ViGeneron announces EMA Approval of Clinical Trial Application for VG901, a gene therapy to treat Retinitis Pigmentosa – Biotech Investments

EQS-News: ViGeneron GmbH / Key word(s): Regulatory Approval ViGeneron announces EMA Approval of Clinical Trial Application for VG901, a gene therapy to treat Retinitis Pigmentosa

August 23, 2023

Patent thickets and terminal disclaimers: How pharma blocks biosimilars from the marketplace

To ring the register, a pharmaceutical company may create a patent thicket, which involves filing dozens of patents that, in some cases, add little value

December 21, 2023

Danaher/Abcam deal set to close next month; Cereno’s loan; March Biosciences to advance its CAR-T into PhII

Danaher’s proposed acquisition of Abcam is expected to close Dec. 6: The companies announced the closing date on Friday. Danaher is paying $24 a share

November 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.